The U.S. health regulator on Wednesday approved Switzerland-based Ferring Pharmaceuticals' fecal transplant-based therapy to reduce the recurrence of a bacterial infection, making it the first therapy of its kind to be cleared in the United States.
🔗Read more
🇺🇸Join👉 @SGTnewsNetwork
📎Twitter▪️IG▪️Truth Social